The tariff classification of Febuxostat Tablets and Estradiol Transdermal System (twice weekly) in dosage form, from India
Reasoning
The tariff classification of Febuxostat Tablets and Estradiol Transdermal System (twice weekly) in dosage form, from India
Cite this ruling
CBP Ruling N303842 (3004390050): The tariff classification of Febuxostat Tablets and Estradiol Transdermal System (twice weekly) in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300439
The tariff classification of GlucaGen® HypoKit from Denmark
The tariff classification of a Pen Injector Delivery System from Switzerland
The tariff classification of Nutropin® [somatotropin (rDNA origin) for injection, Nutropin AQ® [somatotropin (rDNA origin) for injection], Nutropin Depot™ [somatotropin (rDNA origin) for injectable suspension] and Protropin® (somatrem for injection)
The tariff classification of Alprostadil (CAS-745-65-3), imported in bulk form, and MUSE® (alprostadil) urethral suppository
The tariff classification of Biomed 101 capsules and Atamestane tablets from Canada